French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)

René‐Jean Bensadoun, Karen Bénézery, O. Dassonville, +17

International Journal of Radiation Oncology*Biology*Physics

Unresectable Pharyngeal CarcinomaRadiation TherapyMedicineCisplatin/5-fluorouracil ChemotherapyMolecular Oncology +7

Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients

Nicolas Magné, Pierre‐Yves Marcy, Cyril Foa, +4

European Archives of Oto-Rhino-Laryngology

Advanced HeadPercutaneous Fluoroscopic GastrostomyNasogastric Tube FeedingGastroenterologySurgery +6

Concomitant twice‐a‐day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long‐term quality of life analysis

Nicolas Magné, Pierre Yves Marcy, Emmanuel Chamorey, +5

Head & Neck

Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose

Nicolas Magné, S. Marcié, Jean‐Philippe Pignol, +2

British Journal of Radiology

Adaptive RadiotherapyNeuro-oncologyRadiation TherapyMedicineRadionuclide Therapy +12

Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression

Nadia Malkoun, Cyrus Chargari, Fabien Forest, +9

Journal of Neuro-Oncology

Neuro-oncologyProlonged TemozolomideMedicinePrognostic ValuePharmacology +8

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

Anne Laprie, S. Ken, Thomas Filleron, +22

BMC Cancer

Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU‐related toxicity

Nicolas Magné, Marie-Christine Étienne-Grimaldi, L. Cals, +4

British Journal of Clinical Pharmacology

NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib

Léo Aubert, Matthieu Guilbert, Cyril Corbet, +8

Oncotarget

Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)

Anne Laprie, G. Noël, Léonor Chaltiel, +23

Neuro-Oncology

Feasibility of radiation therapy in patients 90years of age and older: A French multicentre analysis

Cyrus Chargari, Guillaume Moriceau, Pierre Auberdiac, +17

European Journal of Cancer

Adaptive RadiotherapyOncologyRadiation TherapyGeriatricsLongevity +9